This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohishi, I Articles by Sakaguchi, G Search for Related Content PubMed PubMed Citation Articles by Ohishi, I Articles by Sakaguchi, G

 Previous Article  |  Next Article 

Infect Immun. 1980 December; 30(3): 668-673

Purification and characterization of two components of botulinum C2 toxin.

ABSTRACT

Two dissimilar proteins, designated as components I and II, of botulinum C2 toxin elaborated by strain 92-13 were purified to a homogeneous state. The molecular weights determined by sodium dodecyl sulfate gel electrophoresis were 55,000 for component I and 105,000 for component II. Whereas each component showed no or feeble toxicity even after being treated with trypsin, the toxicity was elicited when these two components were mixed and trypsinized. The toxicity of the mixture of components I and II at a ratio of 1:2.5 on a protein basis was 2.2 X 10(4) mouse intraperitoneal 50% lethal doses per mg of protein and increased by 2,000 times or more when treated with trypsin. These results indicate that the molecular characteristics of botulinum C2 toxin differ from those of the toxin of Clostridium botulinum types A through F in that C2 toxin is constructed with two separate protein components, which are not covalently held together, and that its toxicity is elicited by cooperation of the two components.

This article has been cited by other articles:

• Neumeyer, T., Schiffler, B., Maier, E., Lang, A. E., Aktories, K., Benz, R. (2008). Clostridium botulinum C2 Toxin: IDENTIFICATION OF THE BINDING SITE FOR CHLOROQUINE AND RELATED COMPOUNDS AND INFLUENCE OF THE BINDING SITE ON PROPERTIES OF THE C2II CHANNEL. J. Biol. Chem. 283: 3904-3914 [Abstract] [Full Text]  
• Heffron, A., Poxton, I. R. (2007). A PCR approach to determine the distribution of toxin genes in closely related Clostridium species: Clostridium botulinum type C and D neurotoxins and C2 toxin, and Clostridium novyi {alpha} toxin. J Med Microbiol 56: 196-201 [Abstract] [Full Text]  
• Barth, H., Aktories, K., Popoff, M. R., Stiles, B. G. (2004). Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins. Microbiol. Mol. Biol. Rev. 68: 373-402 [Abstract] [Full Text]  
• Haug, G., Aktories, K., Barth, H. (2004). The Host Cell Chaperone Hsp90 Is Necessary for Cytotoxic Action of the Binary Iota-Like Toxins. Infect. Immun. 72: 3066-3068 [Abstract] [Full Text]  
• Blocker, D., Pohlmann, K., Haug, G., Bachmeyer, C., Benz, R., Aktories, K., Barth, H. (2003). Clostridium botulinum C2 Toxin: LOW pH-INDUCED PORE FORMATION IS REQUIRED FOR TRANSLOCATION OF THE ENZYME COMPONENT C2I INTO THE CYTOSOL OF HOST CELLS. J. Biol. Chem. 278: 37360-37367 [Abstract] [Full Text]  
• Blocker, D., Barth, H., Maier, E., Benz, R., Barbieri, J. T., Aktories, K. (2000). The C Terminus of Component C2II of Clostridium botulinum C2 Toxin Is Essential for Receptor Binding. Infect. Immun. 68: 4566-4573 [Abstract] [Full Text]  
• Genth, H., Selzer, J., Busch, C., Dumbach, J., Hofmann, F., Aktories, K., Just, I. (2000). New Method To Generate Enzymatically Deficient Clostridium difficile Toxin B as an Antigen for Immunization. Infect. Immun. 68: 1094-1101 [Abstract] [Full Text]  
• Barth, H., Klingler, M., Aktories, K., Kinzel, V. (1999). Clostridium botulinum C2 Toxin Delays Entry into Mitosis and Activation of p34cdc2 Kinase and cdc25-C Phosphatase in HeLa cells. Infect. Immun. 67: 5083-5090 [Abstract] [Full Text]  
• Barth, H., Olenik, C., Sehr, P., Schmidt, G., Aktories, K., Meyer, D. K. (1999). Neosynthesis and Activation of Rho by Escherichia coli Cytotoxic Necrotizing Factor (CNF1) Reverse Cytopathic Effects of ADP-ribosylated Rho. J. Biol. Chem. 274: 27407-27414 [Abstract] [Full Text]  
• Barth, H., Preiss, J. C., Hofmann, F., Aktories, K. (1998). Characterization of the Catalytic Site of the ADP-Ribosyltransferase Clostridium botulinum C2 Toxin by Site-directed Mutagenesis. J. Biol. Chem. 273: 29506-29511 [Abstract] [Full Text]  
• Barth, H., Hofmann, F., Olenik, C., Just, I., Aktories, K. (1998). The N-Terminal Part of the Enzyme Component (C2I) of the Binary Clostridium botulinum C2 Toxin Interacts with the Binding Component C2II and Functions as a Carrier System for a Rho ADP-Ribosylating C3-Like Fusion Toxin. Infect. Immun. 66: 1364-1369 [Abstract] [Full Text]  
• Koch, G., Benz, C., Schmidt, G., Olenik, C., Aktories, K. (1997). Role of Rho Protein in Lovastatin-Induced Breakdown of Actin Cytoskeleton. J. Pharmacol. Exp. Ther. 283: 901-909 [Abstract] [Full Text]  
• Prepens, U., Just, I., von Eichel-Streiber, C., Aktories, K. (1996). Inhibition of Fc[IMAGE]RI-mediated Activation of Rat Basophilic Leukemia Cells by Clostridium difficile Toxin B (Monoglucosyltransferase). J. Biol. Chem. 271: 7324-7329 [Abstract] [Full Text]  
• Barth, H., Blocker, D., Behlke, J., Bergsma-Schutter, W., Brisson, A., Benz, R., Aktories, K. (2000). Cellular Uptake of Clostridium botulinum C2 Toxin Requires Oligomerization and Acidification. J. Biol. Chem. 275: 18704-18711 [Abstract] [Full Text]